286 related articles for article (PubMed ID: 21983942)
1. Claudin-1 induced sealing of blood-brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis.
Pfeiffer F; Schäfer J; Lyck R; Makrides V; Brunner S; Schaeren-Wiemers N; Deutsch U; Engelhardt B
Acta Neuropathol; 2011 Nov; 122(5):601-14. PubMed ID: 21983942
[TBL] [Abstract][Full Text] [Related]
2. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
[TBL] [Abstract][Full Text] [Related]
3. Claudin-12 is not required for blood-brain barrier tight junction function.
Castro Dias M; Coisne C; Baden P; Enzmann G; Garrett L; Becker L; Hölter SM; ; Hrabě de Angelis M; Deutsch U; Engelhardt B
Fluids Barriers CNS; 2019 Sep; 16(1):30. PubMed ID: 31511021
[TBL] [Abstract][Full Text] [Related]
4. Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme.
Wolburg H; Wolburg-Buchholz K; Kraus J; Rascher-Eggstein G; Liebner S; Hamm S; Duffner F; Grote EH; Risau W; Engelhardt B
Acta Neuropathol; 2003 Jun; 105(6):586-92. PubMed ID: 12734665
[TBL] [Abstract][Full Text] [Related]
5. Endothelial α6β4 integrin protects during experimental autoimmune encephalomyelitis-induced neuroinflammation by maintaining vascular integrity and tight junction protein expression.
Welser JV; Halder SK; Kant R; Boroujerdi A; Milner R
J Neuroinflammation; 2017 Nov; 14(1):217. PubMed ID: 29121970
[TBL] [Abstract][Full Text] [Related]
6. Blood-brain barrier genetic disruption leads to protective barrier formation at the Glia Limitans.
Mora P; Hollier PL; Guimbal S; Abelanet A; Diop A; Cornuault L; Couffinhal T; Horng S; Gadeau AP; Renault MA; Chapouly C
PLoS Biol; 2020 Nov; 18(11):e3000946. PubMed ID: 33253145
[TBL] [Abstract][Full Text] [Related]
7. Appearance of claudin-5
Paul D; Baena V; Ge S; Jiang X; Jellison ER; Kiprono T; Agalliu D; Pachter JS
J Neuroinflammation; 2016 Nov; 13(1):292. PubMed ID: 27852330
[TBL] [Abstract][Full Text] [Related]
8. Astrocyte mediated modulation of blood-brain barrier permeability does not correlate with a loss of tight junction proteins from the cellular contacts.
Hamm S; Dehouck B; Kraus J; Wolburg-Buchholz K; Wolburg H; Risau W; Cecchelli R; Engelhardt B; Dehouck MP
Cell Tissue Res; 2004 Feb; 315(2):157-66. PubMed ID: 14615934
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis.
Lanz TV; Becker S; Osswald M; Bittner S; Schuhmann MK; Opitz CA; Gaikwad S; Wiestler B; Litzenburger UM; Sahm F; Ott M; Iwantscheff S; Grabitz C; Mittelbronn M; von Deimling A; Winkler F; Meuth SG; Wick W; Platten M
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14735-40. PubMed ID: 23959874
[TBL] [Abstract][Full Text] [Related]
10. Adenosine A2A receptor agonist ameliorates EAE and correlates with Th1 cytokine-induced blood brain barrier dysfunction via suppression of MLCK signaling pathway.
Liu Y; Alahiri M; Ulloa B; Xie B; Sadiq SA
Immun Inflamm Dis; 2018 Mar; 6(1):72-80. PubMed ID: 29027376
[TBL] [Abstract][Full Text] [Related]
11. Blood-brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE.
Bennett J; Basivireddy J; Kollar A; Biron KE; Reickmann P; Jefferies WA; McQuaid S
J Neuroimmunol; 2010 Dec; 229(1-2):180-91. PubMed ID: 20832870
[TBL] [Abstract][Full Text] [Related]
12. The protective effects of bioactive (RS)-glucoraphanin on the permeability of the mice blood-brain barrier following experimental autoimmune encephalomyelitis.
Giacoppo S; Galuppo M; Iori R; De Nicola GR; Bramanti P; Mazzon E
Eur Rev Med Pharmacol Sci; 2014; 18(2):194-204. PubMed ID: 24488908
[TBL] [Abstract][Full Text] [Related]
13. Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
Souza PS; Gonçalves ED; Pedroso GS; Farias HR; Junqueira SC; Marcon R; Tuon T; Cola M; Silveira PCL; Santos AR; Calixto JB; Souza CT; de Pinho RA; Dutra RC
Mol Neurobiol; 2017 Aug; 54(6):4723-4737. PubMed ID: 27447807
[TBL] [Abstract][Full Text] [Related]
14. Endothelial Wnt/β-catenin signaling reduces immune cell infiltration in multiple sclerosis.
Lengfeld JE; Lutz SE; Smith JR; Diaconu C; Scott C; Kofman SB; Choi C; Walsh CM; Raine CS; Agalliu I; Agalliu D
Proc Natl Acad Sci U S A; 2017 Feb; 114(7):E1168-E1177. PubMed ID: 28137846
[TBL] [Abstract][Full Text] [Related]
15. RGMa Participates in the Blood-Brain Barrier Dysfunction Through BMP/BMPR/YAP Signaling in Multiple Sclerosis.
Zhang L; Tang S; Ma Y; Liu J; Monnier P; Li H; Zhang R; Yu G; Zhang M; Li Y; Feng J; Qin X
Front Immunol; 2022; 13():861486. PubMed ID: 35664003
[TBL] [Abstract][Full Text] [Related]
16. Claudin-1-Dependent Destabilization of the Blood-Brain Barrier in Chronic Stroke.
Sladojevic N; Stamatovic SM; Johnson AM; Choi J; Hu A; Dithmer S; Blasig IE; Keep RF; Andjelkovic AV
J Neurosci; 2019 Jan; 39(4):743-757. PubMed ID: 30504279
[TBL] [Abstract][Full Text] [Related]
17. Idazoxan reduces blood-brain barrier damage during experimental autoimmune encephalomyelitis in mouse.
Wang XS; Fang HL; Chen Y; Liang SS; Zhu ZG; Zeng QY; Li J; Xu HQ; Shao B; He JC; Hou ST; Zheng RY
Eur J Pharmacol; 2014 Aug; 736():70-6. PubMed ID: 24797785
[TBL] [Abstract][Full Text] [Related]
18. Astrocytic tight junctions control inflammatory CNS lesion pathogenesis.
Horng S; Therattil A; Moyon S; Gordon A; Kim K; Argaw AT; Hara Y; Mariani JN; Sawai S; Flodby P; Crandall ED; Borok Z; Sofroniew MV; Chapouly C; John GR
J Clin Invest; 2017 Aug; 127(8):3136-3151. PubMed ID: 28737509
[TBL] [Abstract][Full Text] [Related]
19. Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice.
Girolamo F; Errede M; Longo G; Annese T; Alias C; Ferrara G; Morando S; Trojano M; Kerlero de Rosbo N; Uccelli A; Virgintino D
PLoS One; 2019; 14(3):e0213508. PubMed ID: 30870435
[TBL] [Abstract][Full Text] [Related]
20. Novel 3D analysis of Claudin-5 reveals significant endothelial heterogeneity among CNS microvessels.
Paul D; Cowan AE; Ge S; Pachter JS
Microvasc Res; 2013 Mar; 86():1-10. PubMed ID: 23261753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
